These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. The use of prior information in the testing of new drugs. Allen DM Biometrics; 1971 Sep; 27(3):699-708. PubMed ID: 4940382 [No Abstract] [Full Text] [Related]
7. Advances in pediatric pharmacology, therapeutics, and toxicology. Berlin CM Adv Pediatr; 2001; 48():439-64. PubMed ID: 11480767 [TBL] [Abstract][Full Text] [Related]
8. Clinical development of atypical antipsychotics: research design and evaluation. Collaborative Working Group on Clinical Trial Evaluations. J Clin Psychiatry; 1998; 59 Suppl 12():10-6. PubMed ID: 9766614 [TBL] [Abstract][Full Text] [Related]
9. Alternative strategies in drug development: clinical pharmacological aspects. Kuhlmann J Int J Clin Pharmacol Ther; 1999 Dec; 37(12):575-83. PubMed ID: 10599949 [TBL] [Abstract][Full Text] [Related]
10. [Placebo-controlled antidepressant drug trials. Considering the ethical implications]. Deisenhammer EA; Hinterhuber H Fortschr Neurol Psychiatr; 2003 May; 71(5):243-8. PubMed ID: 12740755 [TBL] [Abstract][Full Text] [Related]
11. Drug research: from the idea to the product. Kuhlmann J Int J Clin Pharmacol Ther; 1997 Dec; 35(12):541-52. PubMed ID: 9455711 [TBL] [Abstract][Full Text] [Related]
12. [PLACEBOS AND THE CLINICAL EVALUATION OF DRUGS]. ASPERGER Z Lijec Vjesn; 1963 Oct; 85():1162-4. PubMed ID: 14097622 [No Abstract] [Full Text] [Related]